Clinical trial
Cocaine Abuse and Attention Deficit Disorder - 3
NCT00000268 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000268 |
|---|---|
| Title | Cocaine Abuse and Attention Deficit Disorder - 3 |
| Official title | Cocaine Abuse and Attention Deficit Disorder |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | New York State Psychiatric Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Bupropion |
| Enrollment | 32 |
| Start date | May 1, 1995 |
| Completion | Nov 1, 1998 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: